Efficacy and safety of nanohybrids comprising silver nanoparticles and silicate clay for controlling Salmonella infection

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2421-2432

  Chiao, Shu Her ^a   Lin, Siou Hong ^a   Shen, Ching I ^a   Liao, Jiunn Wang ^a   Bau, I Jiuan ^a   Wei, Jiun Chiou ^b   Tseng, Li Ping ^a   Hsu, Shan hui ^b   Lai, Ping Shan ^a   Lin, Shinn Zong ^c,d   Lin, Jiang Jen ^b   Su, Hong Lin ^a,c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

Biocompatibility; Cytotoxicity; Infection; Nanoparticle; Silver

Indexed keywords

ANTIINFECTIVE AGENT; NANOSCALE SILICATE PLATELET; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CHICK; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SYNTHESIS; GROWTH INHIBITION; INFECTION PREVENTION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; QUANTITATIVE ANALYSIS; SALMONELLA GALLINARUM; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEPTICEMIA;

ALUMINUM SILICATES; ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; DRUG STABILITY; INTESTINES; MATERIALS TESTING; METAL NANOPARTICLES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SEPSIS; SILVER; SURVIVAL ANALYSIS;

BACTERIA (MICROORGANISMS); SALMONELLA;

EID: 84870336777     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S31594     Document Type: Article

References (36)

1. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol. 2008;74(7):2171-2178.
2. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3(1):95-101.
3. Lok CN, Ho CM, Chen R, et al. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem. 2007;12(4):527-534.
4. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 2007;3(2):168-171.
5. Choi O, Deng KK, Kim NJ, Ross L Jr, Surampalli RY, Hu Z. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 2008;42(12):3066-3074.
6. Su HL, Lin SH, Wei JC, et al. Novel nanohybrids of silver particles on clay platelets for inhibiting silver-resistant bacteria. PLoS One. 2011; 6(6):e21125.
7. Fondevila M, Herrer R, Casallas MC, Abecia L, Ducha JJ. Silver nanoparticles as a potential antimicrobial additive for weaned pigs. Anim Feed Sci Technol. 2009;150:259-269.
8. Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett. 2009;190(2):156-162.
9. Bilberg K, Hovgaard MB, Besenbacher F, Baatrup E. In vivo toxicity of silver nanoparticles and silver ions in zebrafish (Danio rerio). J Toxicol. 2012;doi:10.1155/2012:293784.
10. Brandt O, Mildner M, Egger AE, et al. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomedicine. 2011. doi:10.1016/j. nano.2011.1007.1005.
11. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275(1):177-182.
12. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010; 28(11):580-588.
13. Li PR, Wei JC, Chiu YF, Su HL, Peng FC, Lin JJ. Evaluation on cytotoxicity and genotoxicity of the exfoliated silicate nanoclay. ACS Appl Mater Interfaces. 2010;2(6):1608-1613.
14. Wei JC, Yen YT, Su HL, Lin JJ. Inhibition of bacterial growth by the exfoliated clays and observation of physical capturing mechanism. J Phys Chem C. 2011;115:18770-18775.
15. Wang MC, Lin JJ, Tseng HJ, Hsu SH. Characterization, antimicrobial activities, and biocompatibility of organically modified clays and their nanocomposites with polyurethane. ACS Appl Mater Interfaces. 2011; 4(1):338-350.
16. Lin JJ, Lin WC, Dong RX, Hsu SH. The cellular responses and antibacterial activities of silver nanoparticles stabilized by different polymers. Nanotechnology. 2012;23(6):065102.
17. Hsu SH, Tseng HJ, Hung HS, et al. Antimicrobial activities and cellular responses to natural silicate clays and derivatives modified by cationic alkylamine salts. ACS Appl Mater Interfaces. 2009;1(11):2556-2564.
18. Su HL, Chou CC, Hung DJ, et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials. 2009;30(30):5979-5987.
19. Lin JJ, Hsu YC, Wei KL. Mechanistic aspects of clay intercalation with amphiphilic poly(styrene-co-maleic anhydride)-grafting polyamine salts. Macromolecules. 2007;40(5):1579-1584.
20. Roy P, Dhillon AS, Shivaprasad HL, Schaberg DM, Bandli D, Johnson S. Pathogenicity of different serogroups of avian salmonellae in specific-pathogen-free chickens. Avian Dis. 2001;45(4):922-937.
21. Waltman WD, Mallinson ET. Isolation of Salmonella from poultry tissue and environmental samples: a nationwide survey. Avian Dis. 1995; 39(1):45-54.
22. Chiu CW, Hong PD, Lin JJ. Clay-mediated synthesis of silver nanoparticles exhibiting low-temperature melting. Langmuir. 2011;27(18): 11690-11696.
23. Bihari P, Vippola M, Schultes S, et al. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol. 2008;5:14.
24. Maeda H, Ueda M, Morinaga T, Matsumoto T. Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties. J Med Chem. 1985;28(4):455-461.
25. Greish K, Sawa T, Fang J, Akaike T, Maeda H. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. J Control Release. 2004;97(2):219-230.
26. Donati I, Gamini A, Vetere A, Campa C, Paoletti S. Synthesis, characterization, and preliminary biological study of glycoconjugates of poly(styrene-co-maleic acid). Biomacromolecules. 2002;3(4): 805-812.
27. Loeschner K, Hadrup N, Qvortrup K, et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol. 2011;8:18.
28. Musikasang H, Tani A, H-kittikun A, Maneerat S. Probiotic potential of lactic acid bacteria isolated from chicken gastrointestinal digestive tract. World J Microbiol Biotechnol. 2009;25:1337-1345.
29. Finlay BB, Brumell JH. Salmonella interactions with host cells: in vitro to in vivo. Philos Trans R Soc Lond B Biol Sci. 2000;355(1397): 623-631.
30. Gopinath P, Gogoi SK, Chattopadhyay A, Ghosh SS. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology. 2008;19(7):075104.
31. Florence AT. The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual. Pharm Res. 1997;14(3):259-266.
32. Moffat DB, Creasey M. The distribution of ingested silver in the kidney of the rat and of the rabbit. Acta Anat (Basel). 1972;83(3):346-355.
33. Creasey M, Moffat DB. The deposition of ingested silver in the rat kidney at different ages. Experientia. 1973;29(3):326-327.
34. Park EJ, Bae E, Yi J, et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol. 2010;30(2):162-168.
35. Kim YS, Kim JS, Cho HS, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2008;20(6):575-583.
36. Kim YS, Song MY, Park JD, et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol. 2010;7:20.